This document discusses the management of urinary tract infections (UTIs) in females from newborns to the elderly. It covers topics such as pathogenesis, classifications, symptoms, diagnosis, treatment for various types of UTIs including cystitis, pyelonephritis, and urethritis. It also discusses considerations for recurrent UTIs, UTIs in special populations like pregnant and post-menopausal women, as well as pediatric UTIs. The development of antibiotic resistance is a growing problem discussed.
a presentation about UTI. information from various textbooks and different journals and also from many peoples presentation is accumulated in this one file. i worked very hard for this project.
a presentation about UTI. information from various textbooks and different journals and also from many peoples presentation is accumulated in this one file. i worked very hard for this project.
Urinary tract infection- a detailed medical study martinshaji
HAPPY PHARMACIST DAY
An infection in any part of the urinary system, the kidneys, bladder or urethra.
Urinary tract infections are more common in women. They usually occur in the bladder or urethra, but more serious infections involve the kidney.
A bladder infection may cause pelvic pain, increased urge to urinate, pain with urination and blood in the urine.
this study details all about UTI
please comment
thank you
Recurrent UTI might be one of the most common problems in urology clinics.Treating UTI might not be difficult, but preventing UTI recurrence sometimes might be very troublesome for both patients and doctors.
Symptomatic presence of micro-organisms within the urinary tract i.e., kidney, ureters, bladder and urethra.
• Associated with inflammation of urinary tract.
Urinary tract infection- a detailed medical study martinshaji
HAPPY PHARMACIST DAY
An infection in any part of the urinary system, the kidneys, bladder or urethra.
Urinary tract infections are more common in women. They usually occur in the bladder or urethra, but more serious infections involve the kidney.
A bladder infection may cause pelvic pain, increased urge to urinate, pain with urination and blood in the urine.
this study details all about UTI
please comment
thank you
Recurrent UTI might be one of the most common problems in urology clinics.Treating UTI might not be difficult, but preventing UTI recurrence sometimes might be very troublesome for both patients and doctors.
Symptomatic presence of micro-organisms within the urinary tract i.e., kidney, ureters, bladder and urethra.
• Associated with inflammation of urinary tract.
Management of RECURRENT URINARY TRACT INFECTION, Dr. Sharda Jain, Dr. Jyoti ...Lifecare Centre
Management of RECURRENT URINARY TRACT INFECTION
OVERVIEW
Challenge of Recurrent UTI
What is Recurrent UTI
Risks
prevention
Management of recurrent UTI
Cranberry & D-mannose Tablets
Composition
Clinical Studies
Indication
Dosage & Administration
Contraindications
Warnings & Precautions
Adverse Events
Take Home Massages
FAQs
First Urinary Tract Infection Episode in Children: Are Procalcitonin Values & US Examination of Importance in the Diagnosis of Upper Urinary Tract Infection ?
Interstitial cystitis is a long-term
(chronic) inflammation of the bladder wall.
Treatment results vary. Some people respond well to simple treatments
and dietary changes. Others may require extensive treatments or surgery.
Urinary Tract Infection with Nursing ManagementSwatilekha Das
Urinary Tract Infection introduction, definition, common microorganisms, classification, predisposing factors, clinical manifestations, pathophysiology, diagnostic studies, medical management and nursing management along with assessment, nursing diagnosis, goal, nursing interventions and expected outcome after the intervention.
Uncomplicated UTI in Adult and Pregnant Woman,Dr. Sharda jain, Dr. Jyoti Bha...Lifecare Centre
Our Teamdedicated for giving knowledge & skill to doctors
Urinary Tract Infection (UTI)
UTI is the 2nd most common infectious presentation in community practice.
World wide, about 150 million people are diagnosed with UTI each year.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Management of Urinary Tract Infections (UTI) in Females (New Born to Elderly)
1. Management of
Urinary Tract Infections (UTI)
in Females (New Born to Elderly)
Dr Abdul Fatah
MS, MCh (Uro)
Consultant Urologist, Endo - Urologist
Specialist in Reconstructive Urology
2. Problem
Urinary tract infections (UTIs) are among
the most prevailing infectious diseases with
a substantial financial burden on society
Approximately 10-15% of all community-
prescribed antibiotics in the world are
dispensed for UTI
Development of resistance
3. Development of Resistance
Steady increase in ESBL producing bacteria showing
resistance to most antibiotics, except for the
carbapenem group
Recent reports from all continents of faecal bacteria
carrying the ESBLCARBA enzyme (i.e New-Dehli
metallo-b-lactamase NDM-1) making them resistant to
all available antibiotics including the carbapenem
group
Increasing resistance to broad-spectrum antibiotics
such as fluoroquinolones and cephalosporins
This development is a threat for patients undergoing
urological surgery
4. Pathogenesis
Ascent of microorganisms from the urethra is the most
common pathway
A single insertion of a catheter into the urinary bladder in
ambulatory patients results in urinary infection in 1-2% of
cases.
Indwelling catheters with open-drainage systems result in
bacteriuria in almost 100% of cases within 3-4 days.
Haematogenous infection of the urinary tract is restricted
to a few relatively uncommon microbes, such as
Staphylococcus aureus, Candida sp., Salmonella sp. and
Mycobacterium tuberculosis
5. • Bacterial strains are uniquely equipped with specialised
virulence factors, e.g. different types of pili, which facilitate
the ascent of bacteria from the faecal flora, introitus vaginae
or periurethral area up the urethra into the bladder, or less
frequently, allow the organisms to reach the kidneys
Pathogenesis
6. UTI classifications
Based on Anatomical level of infection
Upper urinary tract Infections:
Pyelonephritis
Pyelitis
ureteritis
Lower urinary tract infections
Cystitis (“traditional” UTI)
Urethritis (often sexually-transmitted)
Prostatitis
UROSEPSIS- bacteria in blood stream
9. Findings on Exam in UTI
Physical Exam:
CVA tenderness (pyelonephritis)
Urethral discharge (urethritis)
Supra pubic tenderness
Labs: Urinalysis
More likely gram-negative rods
WBCs
RBCs
10. Culture in UTI
The number of bacteria is considered relevant for the
diagnosis of a UTI
Positive Urine Culture = >105 CFU/mL
It has recently become clear that there is no fixed bacterial
count that is indicative of significant bacteriuria, which can be
applied to all kinds of UTIs and in all circumstances
11. Following bacterial counts are clinically relevant:
> 103cfu/mL of uropathogens in a mid-stream sample of urine (MSU) in acute
uncomplicated cystitis in women.
> 104cfu/mL of uropathogens in an MSU in acute uncomplicated pyelonephritis in
women.
> 105 cfu/mL of uropathogens in an MSU in women, or > 104cfu/mL uropathogens in an
MSU in men, or in straight catheter urine in women, in a complicated UTI.
In a suprapubic bladder puncture specimen, any count of bacteria is relevant
Culture in UTI
12. Most common pathogen for
cystitis, prostatitis, pyelonephritis:
Escherichia coli
Staphylococcus saprophyticus
Proteus mirabilis
Klebsiella
Enterococcus
Most common pathogen for urethritis
Chlamydia trachomatis
Neisseria Gonorrhea
Culture in UTI
13. Lower Urinary Tract Infection - Cystitis
Uncomplicated (Simple) cystitis
In healthy woman, with no signs of systemic
disease
Complicated cystitis
In men, or woman with comorbid medical
problems.
Recurrent cystitis
14. Uncomplicated (simple) Cystitis
Definition
Healthy adult woman (over age 12)
Non-pregnant
No fever, nausea, vomiting, flank pain
Diagnosis
Dipstick urinalysis (no culture or lab tests needed)
Risk factors:
Sexual intercourse
Post-coital voiding or prophylactic antibiotic use recommended.
Urine cultures are recommended for those with: (i) suspected acute
pyelonephritis; (ii) symptoms that do not resolve or recur within 2-4
weeks after the completion of treatment; and (iii) those women who
present with atypical symptoms
15. Treatment
Trimethroprim/Sulfamethoxazole or fluoroquinolone for 3 days
• Women who present with atypical symptoms as well as
those who fail to respond to appropriate antimicrobial
therapy should be considered for additional diagnostic
studies
• Routine post-treatment urinalysis or urine cultures in
asymptomatic patients are not indicated
• Recurrence of symptoms-Retreatment with a 7-day regimen
using another agent should be considered
Uncomplicated (simple) Cystitis
16. Complicated Cystitis
Definition
Females with comorbid medical conditions
All male patients
Indwelling foley catheters
Urosepsis/hospitalization
Diagnosis
Urinalysis, Urine culture
Further labs, if appropriate.
Treatment
Fluoroquinolone (or other broad spectrum antibiotic)
7-14 days of treatment (depending on severity) in females
17. Special cases of Complicated cystitis
Indwelling foley catheter
Try to get rid of foley if possible!
Only treat patient when symptomatic (fever, dysuria)
Leukocytes on urinalysis
Patient’s with indwelling catheters are frequently colonized with great
deal of bacteria.
Candiduria
Frequently occurs in patients with indwelling foley.
If grows in urine, try to get rid of foley!
Treat only if symptomatic.
If need to treat, give fluconazole (amphotericin if resistance)
18. Acute Pyelonephritis
Defn; Infection of the kidney with triad of fever with chills
flank pain and pyuria
Suggested by fever, nausea, vomiting, headache and
costovertebral angle tenderness features of cystitis may not
be present
Diagnosis:
Urinalysis, urine culture, CBC, RFT
Evaluation of the upper urinary tract with ultrasound should be
performed to rule out urinary obstruction or renal stone disease
Additional investigations, such as an unenhanced helical computed tomography
(CT), excretory urography, or dimercaptosuccinic acid (DMSA) scanning, should be
considered if the patients remain febrile after 72 h of treatment
19. Treatment:
2-weeks of fluoroquinolone
Cotrimoxazole is not recommended unless sensitivity
is known
Hospitalization and IV antibiotics if patient unable to
take po.
Initial empirical therapy with an aminoglycoside or
carbapenem has to be considered if resistance to
fluoroquinolones and other antibiotics is >10% in the
community
Acute Pyelonephritis
20. Complications:
Perinephric/Renal abscess:
Suspect in patient who is not improving on antibiotic
therapy.
Diagnosis: CT with contrast, renal ultrasound
May need surgical drainage.
Nephrolithiasis with UTI
Suspect in patient with severe flank pain
Acute Pyelonephritis
21. In women whose pyelonephritis symptoms do not improve within 3 days,
or resolve and then recur within 2 weeks, repeated urine culture and
antimicrobial susceptibility tests and an appropriate investigations are
required
If no urological abnormality, it should be assumed that the infecting
organism is not susceptible to the agent originally used, and an alternative
treatment should be considered based on culture results
For patients who relapse with the same pathogen, the diagnosis of
uncomplicated pyelonephritis should be reconsidered. Appropriate
diagnostic steps are necessary to rule out any complicating factors
Acute Pyelonephritis
22. Recurrent UTI’s in women
Two episodes in 6 months or 3 episodes in a year
Quiet common in sexually active female even though there is
no anatomical or physiological abnormality
Recurrent UTIs to be diagnosed by urine culture
Apart from Ultrasound KUB ,Excretory urography, cystography
and cystoscopy are not routinely recommended for evaluation
of women with recurrent UTIs
23. Prevention of recurrent UTI’s
Antimicrobial prophylaxis
Immunoactive prophylaxis
Prophylaxis with probiotics
Prophylaxis with cranberry
24. Antimicrobial prophylaxis
After counselling and behavioural modification
has been attempted
Before any prophylaxis regimen is
initiated, eradication of a previous UTI should be
confirmed
Continuous or postcoital antimicrobial
prophylaxis
Cephalexin 250 mg once daily
Norfloxacin 200 mg once daily
Ciprofloxacin 125 mg once daily
25. Immunoactive prophylaxis
Uro-Vaxom, an oral vaccine against Escherichia coli
Has been shown to be more effective than placebo
in several randomised trials.
Recommended for immunoprophylaxis in female
patients with recurrent uncomplicated UTI
26. Prophylaxis with probiotics
Restore the vaginal lactobacilli
Compete with urogenital
pathogens
Prevent bacterial vaginosis, a
condition that increases the risk of
UTI
27. Prophylaxis with cranberry
Useful in reducing the rate
of lower UTIs in women
Daily consumption of
cranberry products, giving a
minimum of 36 mg/day
proanthocyanindin A (the
active compound)
28. UTI’s in post menopausal women
In older institutionalised women, urine
catheterisation and functional status deterioration
most important risk factors associated with UTI
Atrophic vaginitis
Incontinence, cystocele and post-voiding residual
urine
UTI before menopause
Non-secretor status of blood group antigens.
29. UTI’s in post menopausal women
History, physical examination and
urinalysis, including culture
Rule out urinary tract obstruction such as
urethral stenosis
Genitourinary symptoms are not necessarily
related to UTI and an indication for
antimicrobial treatment
30. UTI’s in post menopausal women
Treatment is similar to
premenopusal women
however asymptomatic
bacteriuria should not be
treated
Cystoscopy and urethral
dilatation in obstructive
symptoms with high PVR
on USG
31. UTI’s in post menopausal women
Oestrogen cream( vaginal) can be
administered for prevention of UTI
Alternative methods, such as cranberry and
probiotic lactobacilli, can contribute but they
are not sufficient to prevent recurrent UTI.
32. UTI’s in pregnancy
Urinary tract infections and asymptomatic
bacteriuria are common during pregnancy
20-40% of women with asymptomatic
bacteriuria develop pyelonephritis during
pregnancy
Ultrasound of the kidneys and urinary tract is
necessary
Pregnant women should be screened for
bacteriuria during the first trimester
33. UTI’s in pregnancy
Nitrofurantoin 100 mg q12 h, 3-5 days (Avoid
in G6PD deficiency)
Amoxicillin 500 mg q8 h, 3-5 days
Co-amoxicillin/clavulanate 500 mg q12 h, 3-5
days
Cephalexin 500 mg q8 h, 3-5 days
Trimethoprim q12 h, 3-5 days Avoid
trimethoprim in first trimester/term
34. UTI’s in pregnancy
Urine cultures should be obtained 1-2 weeks
after completion of therapy for asymptomatic
bacteriuria and symptomatic UTI in pregnancy
Postcoital prophylaxis should be considered in
pregnant women with a history of frequent
UTIs before onset of pregnancy, to reduce
their risk of UTI
35. Antibiotics for pyelonephritis
Ceftriaxone 1-2 g IV or IM q24 h
Aztreonam 1 g IV q8-12 h
Piperacillin-tazobactam 3.375-4.5 g IV q6 h
Cefepime 1 g IV q12 h
Imipenem-cilastatin 500 mg IV q6 h
Ampicillin + 2 g IV q6 h
Gentamicin 3-5 mg/kg/day IV in 3 divided
doses
36. Pediatric UTI’s
The incidence of UTI varies depending on age and
sex.
In the first year of life, mostly the first 3 months, UTI
is more common in boys (3.7%) than in girls
(2%), after which the incidence changes, being 3% in
girls and 1.1% in boys
The clinical presentation of UTI in infants and young
children can vary from fever to gastrointestinal and
lower or upper urinary tract symptoms
37. Pediatric UTI’s
Investigation should be undertaken after two episodes
of UTI in girls and one in boys
The objective is to rule out the unusual occurrence of
obstruction, vesicoureteric reflux (VUR) and
dysfunctional voiding, e.g. as caused by a neuropathic
disorder
For treatment of UTI in children, short courses are not
advised and therefore treatment is continued for 5-7
days and longer. If the child is severely ill with vomiting
and dehydration, hospital admission is required and
parenteral antibiotics are given initially
39. Urethritis
Chlamydia trachomatis
Frequently asymptomatic in females, but can present with dysuria, discharge or pelvic inflammatory
disease.
Send UA, Urine culture (if pyuria seen, but no bacteria, suspect Chlamydia)
Pelvic exam – send discharge from cervical or urethral os for chlamydia PCR
Chlamydia screening is now recommended for all females ≤ 25 years
Treatment:
Azithromycin – 1 g po x 1
Doxycycline – 100 mg po BID x 7 days
Neisseria gonorrhoeae
May present with dysuria, discharge, PID
Send UA, urine culture
Pelvic exam – send discharge samples for gram stain, culture, PCR
Treatment:
Ceftriaxone – 125 mg IM x 1
Cipro – 500 mg po x 1
Levofloxacin – 250 mg po x 1
Ofloxacin – 400 mg po x 1
Spectinomycin – 2 g IM x 1
You should always also treat for chlamydia when treating for gonnorhea!